Liabilities, Current of BIO-TECHNE Corp from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
BIO-TECHNE Corp quarterly Liabilities, Current in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • BIO-TECHNE Corp Liabilities, Current for the quarter ending 30 Sep 2025 was $144,545,000, a 1.7% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $144,545,000 +$2,417,000 +1.7% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $175,849,000 +$16,470,000 +10% 30 Jun 2025 10-Q 05 Nov 2025 2026 Q1
Q1 2025 $169,204,000 +$19,384,000 +13% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $161,256,000 +$26,025,000 +19% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $142,128,000 +$14,374,000 +11% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $159,379,000 +$30,870,000 +24% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $149,820,000 +$8,657,000 +6.1% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $135,231,000 +$6,836,000 +5.3% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $127,754,000 -$9,875,000 -7.2% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $128,509,000 -$47,509,000 -27% 30 Jun 2023 10-K 22 Aug 2024 2024 FY
Q1 2023 $141,163,000 -$25,675,000 -15% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $128,395,000 -$26,414,000 -17% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $137,629,000 +$3,637,000 +2.7% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $176,018,000 +$23,734,000 +16% 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q1 2022 $166,838,000 +$29,198,000 +21% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $154,809,000 +$37,241,000 +32% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $133,992,000 +$28,568,000 +27% 30 Sep 2021 10-Q 08 Nov 2021 2022 Q1
Q2 2021 $152,284,000 +$45,616,000 +43% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q1 2021 $137,640,000 +$32,655,000 +31% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $117,568,000 +$12,615,000 +12% 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $105,424,000 +$17,156,000 +19% 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $106,668,000 +$4,683,000 +4.6% 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q1 2020 $104,985,000 +$6,938,000 +7.1% 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $104,953,000 +$17,521,000 +20% 31 Dec 2019 10-Q 06 Feb 2020 2020 Q2
Q3 2019 $88,268,000 +$4,826,000 +5.8% 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q2 2019 $101,985,000 +$22,475,000 +28% 30 Jun 2019 10-K 26 Aug 2020 2020 FY
Q1 2019 $98,047,000 +$27,158,000 +38% 31 Mar 2019 10-Q 07 May 2019 2019 Q3
Q4 2018 $87,432,000 -$24,247,000 -22% 31 Dec 2018 10-Q 07 Feb 2019 2019 Q2
Q3 2018 $83,442,000 -$23,589,000 -22% 30 Sep 2018 10-Q 07 Nov 2018 2019 Q1
Q2 2018 $79,510,000 -$56,012,000 -41% 30 Jun 2018 10-K/A 06 Nov 2019 2019 FY
Q1 2018 $70,889,000 -$71,311,000 -50% 31 Mar 2018 10-Q 09 May 2018 2018 Q3
Q4 2017 $111,679,000 -$8,647,000 -7.2% 31 Dec 2017 10-Q 08 Feb 2018 2018 Q2
Q3 2017 $107,031,000 +$15,000 +0.01% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 $135,522,000 +$81,375,000 +150% 30 Jun 2017 10-K 27 Aug 2018 2018 FY
Q1 2017 $142,200,000 +$95,584,000 +205% 31 Mar 2017 10-Q 10 May 2017 2017 Q3
Q4 2016 $120,326,000 +$84,497,000 +236% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q2
Q3 2016 $107,016,000 +$61,976,000 +138% 30 Sep 2016 10-Q 09 Nov 2016 2017 Q1
Q2 2016 $54,147,000 +$14,379,000 +36% 30 Jun 2016 10-K 07 Sep 2017 2017 FY
Q1 2016 $46,616,000 +$8,103,000 +21% 31 Mar 2016 10-Q 10 May 2016 2016 Q3
Q4 2015 $35,829,000 -$8,451,000 -19% 31 Dec 2015 10-Q 09 Feb 2016 2016 Q2
Q3 2015 $45,040,000 +$4,422,000 +11% 30 Sep 2015 10-Q 09 Nov 2015 2016 Q1
Q2 2015 $39,768,000 +$13,377,000 +51% 30 Jun 2015 10-K 29 Aug 2016 2016 FY
Q1 2015 $38,513,000 +$14,149,000 +58% 31 Mar 2015 10-Q 11 May 2015 2015 Q3
Q4 2014 $44,280,000 +$22,171,000 +100% 31 Dec 2014 10-Q 09 Feb 2015 2015 Q2
Q3 2014 $40,618,000 +$20,342,000 +100% 30 Sep 2014 10-Q 10 Nov 2014 2015 Q1
Q2 2014 $26,391,000 -$5,693,000 -18% 30 Jun 2014 10-K 31 Aug 2015 2015 FY
Q1 2014 $24,364,000 -$8,117,000 -25% 31 Mar 2014 10-Q 12 May 2014 2014 Q3
Q4 2013 $22,109,000 +$841,000 +4% 31 Dec 2013 10-Q 04 Feb 2014 2014 Q2
Q3 2013 $20,276,000 -$2,625,000 -11% 30 Sep 2013 10-Q 12 Nov 2013 2014 Q1
Q2 2013 $32,084,000 -$3,666,000 -10% 30 Jun 2013 10-K 29 Aug 2014 2014 FY
Q1 2013 $32,481,000 +$1,760,000 +5.7% 31 Mar 2013 10-Q 10 May 2013 2013 Q3
Q4 2012 $21,268,000 +$7,145,000 +51% 31 Dec 2012 10-Q 11 Feb 2013 2013 Q2
Q3 2012 $22,901,000 -$3,335,000 -13% 30 Sep 2012 10-Q 09 Nov 2012 2013 Q1
Q2 2012 $35,750,000 +$17,562,000 +97% 30 Jun 2012 10-K 29 Aug 2013 2013 FY
Q1 2012 $30,721,000 +$14,179,000 +86% 31 Mar 2012 10-Q 10 May 2012 2012 Q3
Q4 2011 $14,123,000 +$451,000 +3.3% 31 Dec 2011 10-Q 07 Feb 2012 2012 Q2
Q3 2011 $26,236,000 +$10,177,000 +63% 30 Sep 2011 10-Q 09 Nov 2011 2012 Q1
Q2 2011 $18,188,000 +$1,164,000 +6.8% 30 Jun 2011 10-K 29 Aug 2012 2012 FY
Q1 2011 $16,542,000 31 Mar 2011 10-Q 10 May 2011 2011 Q3
Q4 2010 $13,672,000 31 Dec 2010 10-Q 09 Feb 2011 2011 Q2
Q3 2010 $16,059,000 30 Sep 2010 10-Q 09 Nov 2010 2011 Q1
Q2 2010 $17,024,000 30 Jun 2010 10-K 29 Aug 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.